Primary Immunodeficiency
Panel

Distinguish diseases with overlapping symptoms

Autoimmune diseases affect 3-10% of the population.12 However, prevalence varies greatly between different diseases, as well as incidence of the same disease among different demographics.

Primary immunodeficiencies (PIDs) are inherited diseases associated with a considerable increase in susceptibility to infections. It is known that PIDs can also predispose patients to cancer and immune diseases, including allergy, autoimmunity, and inflam mation.

Distinguish diseases with overlapping symptoms

Autoimmune diseases involve activation of the adaptive immune system against self-antigens. They are a diverse group of disor ders. Some are organ specific while others are systematic and affect multiple organ systems. The majority of autoimmune diseases involve multiple factors, both genetic and environmental. However, a minority of autoimmune diseases are monogenic and associ ated with a specific genetic cause. 1

This gene panel helps in the diagnosis of autoimmune diseases, and in complex clinical cases, helps distinguish between diseases with overlapping symptoms to aid in risk assessment.3 This panel tests for diseases including HIV, Pneumocystosis, Nezelof’s Syn drome, Pancytopenia, Myelofibrosis, and more.

Gene list

  • BRCA1 FGB
  • BARC2 MEFV
  • BLM STAT3
  • CFTR BTK
  • BTK ATM
  • F9 VPS13B
  • F5 STAT1
  • FANCC IFNGR1
  • G6PD IFNGR2
  • G6PC RAG1
  • JAK2 RAG2
  • MSH2 SPINK5
  • MSH6 RFXANK
  • MYD88 PTPRC
  • PALB2 NCF1
  • NRAS TNFRSF13B
  • PMS2 ITGB2
  • PLCG2 CYBB
  • PTEN JAGN1
References

1. Human autoimmune diseases: a comprehensive update. Wang L, Wang FS, Gershwin ME. 369-95, s.l. : J Intern Med, 2015, Vol. Oct;278(4). doi: 10.1111/joim.12395.

2. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of dis eases. Cooper GS, Bynum ML, Somers EC. 197-207, s.l. : J Autoimmun, 2009, Vols. Nov-Dec;33(3-4). doi: 10.1016/j.jaut.2009.09.008.

3. Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder re current fevers. Papa R1, Rusmini M2, Volpi S1, Caorsi R1, Picco P1, Grossi A2, Caroli F2, Bovis F3, Musso V, Obici L, Castana C, Ravelli A, Van Gijn ME, Ceccherini I, Gattorno M. 344-360, s.l. : Rheumatology, 2020, Vol. Feb 1;59(2). doi: 10.1093/rheumatology/kez270.

Get in Touch

Ready for answers you can trust?

Partner with our lab for accurate, reliable diagnostic testing with industry-leading turnaround times.

Important Questions

Frequently Asked Questions

Have a question? You might find the answer below in our FAQs!

What is your turnaround time for testing?

We offer same day turnaround time for PCR tests. Toxicology tests will be resulted in 24-36 hours, depending upon targets requested.

Where are you located and how can I sign-up for testing?

We have multiple testing locations across the country. You can book here on our website by selecting your desired testing location.

Do you take insurance?

Most insurances are accepted, but must have doctor’s orders to use insurance. Cash pay rates are available, please contact us for a quote.

How do I receive my results?

Secure results are sent by email or through your provider portal, and can also be shared directly with your referring physician.